Fig. 5

a Pooled analysis showing improved PFS in overweight cancer patients compared with normal patients receiving immune checkpoint inhibitors treatment; b Pooled analysis showing improved PFS in obese cancer patients compared with normal patients receiving immune checkpoint inhibitors treatment